Company / Cost of Revenue
ORTHOPEDIATRICS CORP Cost of Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$37.5M
FY2025
5-year range
$16.0M / $37.5M
FY2021-FY2025
Trend
+18.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has increased for 3 consecutive years, from $16M in FY2022 to $37M in FY2025.
Based on SEC 10-K filings.
$37M in FY2025 with a 5-year CAGR of +20.3%.
Increased from $25M to $37M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +32.7%
- 5-Year CAGR
- +20.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- ORTHOPEDIATRICS CORP's cost of revenue has grown for 3 consecutive years.
- 5-year CAGR of +20.3%, indicating consistent growth.
- In FY2025, cost of revenue increased 18.5% year-over-year.
- Lowest cost of revenue in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $37.5M | +18.5% |
| FY2024 | $31.6M | +28.3% |
| FY2023 | $24.6M | +53.6% |
| FY2022 | $16.0M | -10.5% |
| FY2021 | $17.9M | +20.5% |
| FY2020 | $14.9M | +33.2% |
| FY2019 | $11.2M | +2.2% |
| FY2018 | $10.9M | +16.7% |
| FY2017 | $9.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026